Mark Metersky MD
Critical Care Medicine, Infectious Disease, Pleural Disease
Professor, University of Connecticut School of Medicine
Join to View Full Profile
263 Farmington AveFarmington, CT 06030
Phone+1 860-679-3343
Fax+1 860-679-4256
Dr. Metersky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Boston University Medical CenterResidency, Internal Medicine, 1985 - 1988
New York University School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 1989 - Present
CT State Medical License 1992 - 2025
FL State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top MD Consumers Checkbook
Clinical Trials
- Scleroderma Lung Disease Start of enrollment: 1999 Aug 01
- Bosentan for Poorly Controlled Asthma Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- The rapidly changing paradigms for the diagnosis and treatment of cystic fibrosis, bronchiectasis, and primary ciliary dyskinesia.Mark L Metersky, Douglas J Conrad, Adam J Shapiro
Current Opinion in Pulmonary Medicine. 2025-11-01 - Research Letter: The Association Between Incident Nontuberculous Mycobacteria Isolation and Antibiotic Exposure in Patients with Bronchiectasis.Meghan Marmor, Amanda E Brunton, David Fraulino, Stephen J Ruoss, Emily Henkle
Chest. 2025-10-09 - 1 citationsA profile of brensocatib for non-cystic fibrosis bronchiectasis.Alexander I Geyer, Mark L Metersky
Expert Review of Respiratory Medicine. 2025-08-01
Journal Articles
- Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in BronchiectasisMark L Metersky, Charles L Daley, The New England Journal of Medicine
- Association Between Medicare Expenditures and Adverse Events for Patients with Acute Myocardial Infarction, Heart Failure, or Pneumonia in the United StatesMark L Metersky, Harlan M Krumholz, JAMA Network Open
- Case Report Bordetella Bronchiseptica in Non-Cystic Fibrosis BronchiectasisVanessa L Yap, Elham Karamooz, Mark L Metersky, Alan F Barker, ScienceDirect
Authored Content
- Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013November 2016
- Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013November 2016
Press Mentions
Featured Buzz May 12, 2025May 5th, 2025- Brensocatib Once-Daily Pill Shows Benefits for Chronic Lung DiseaseApril 30th, 2025
- CT Still Feeling Stress of Influenza and Other Respiratory Ailments as Winter Drags OnFebruary 25th, 2025
- Join now to see all
Grant Support
- Obstacles To Usage Of The Pneumoccocal VaccineNational Center For Research Resources1998–1999
- Compliance With Tuberculosis Prophylaxis After Release For Correctional FacilityNational Center For Research Resources1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
